Newsbenzinga
Merck and Moderna's Phase 3 Win Raises the Stakes for BioNTech and Roche (CORRECTED)
· Published
Article summary
Merck & Moderna's partnership reports first Phase 3 success for personalized cancer vaccine, raising stakes for BioNTech & Genentech's program.
An excerpt from the original article.
Comments —
Loading comments…